These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
384 related articles for article (PubMed ID: 30579852)
1. 'Temporary Plasticiser': A novel solution to fabricate 3D printed patient-centred cardiovascular 'Polypill' architectures. Pereira BC; Isreb A; Forbes RT; Dores F; Habashy R; Petit JB; Alhnan MA; Oga EF Eur J Pharm Biopharm; 2019 Feb; 135():94-103. PubMed ID: 30579852 [TBL] [Abstract][Full Text] [Related]
2. From 'fixed dose combinations' to 'a dynamic dose combiner': 3D printed bi-layer antihypertensive tablets. Sadia M; Isreb A; Abbadi I; Isreb M; Aziz D; Selo A; Timmins P; Alhnan MA Eur J Pharm Sci; 2018 Oct; 123():484-494. PubMed ID: 30041029 [TBL] [Abstract][Full Text] [Related]
3. A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery. Gioumouxouzis CI; Baklavaridis A; Katsamenis OL; Markopoulou CK; Bouropoulos N; Tzetzis D; Fatouros DG Eur J Pharm Sci; 2018 Jul; 120():40-52. PubMed ID: 29678613 [TBL] [Abstract][Full Text] [Related]
4. Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. Skowyra J; Pietrzak K; Alhnan MA Eur J Pharm Sci; 2015 Feb; 68():11-7. PubMed ID: 25460545 [TBL] [Abstract][Full Text] [Related]
5. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs. Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104 [TBL] [Abstract][Full Text] [Related]
6. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets. Goyanes A; Buanz AB; Hatton GB; Gaisford S; Basit AW Eur J Pharm Biopharm; 2015 Jan; 89():157-62. PubMed ID: 25497178 [TBL] [Abstract][Full Text] [Related]
7. Non-destructive dose verification of two drugs within 3D printed polyprintlets. Trenfield SJ; Tan HX; Goyanes A; Wilsdon D; Rowland M; Gaisford S; Basit AW Int J Pharm; 2020 Mar; 577():119066. PubMed ID: 31982555 [TBL] [Abstract][Full Text] [Related]
8. Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets. Sadia M; Sośnicka A; Arafat B; Isreb A; Ahmed W; Kelarakis A; Alhnan MA Int J Pharm; 2016 Nov; 513(1-2):659-668. PubMed ID: 27640246 [TBL] [Abstract][Full Text] [Related]
9. Preparation and In vitro Evaluation of FDM 3D-Printed Ellipsoid-Shaped Gastric Floating Tablets with Low Infill Percentages. Chen D; Xu XY; Li R; Zang GA; Zhang Y; Wang MR; Xiong MF; Xu JR; Wang T; Fu H; Hu Q; Wu B; Yan GR; Fan TY AAPS PharmSciTech; 2019 Nov; 21(1):6. PubMed ID: 31754916 [TBL] [Abstract][Full Text] [Related]
10. Fused-filament 3D printing (3DP) for fabrication of tablets. Goyanes A; Buanz AB; Basit AW; Gaisford S Int J Pharm; 2014 Dec; 476(1-2):88-92. PubMed ID: 25275937 [TBL] [Abstract][Full Text] [Related]
11. 3D printing of tablets containing multiple drugs with defined release profiles. Khaled SA; Burley JC; Alexander MR; Yang J; Roberts CJ Int J Pharm; 2015 Oct; 494(2):643-650. PubMed ID: 26235921 [TBL] [Abstract][Full Text] [Related]
12. Fabricating a Shell-Core Delayed Release Tablet Using Dual FDM 3D Printing for Patient-Centred Therapy. Okwuosa TC; Pereira BC; Arafat B; Cieszynska M; Isreb A; Alhnan MA Pharm Res; 2017 Feb; 34(2):427-437. PubMed ID: 27943014 [TBL] [Abstract][Full Text] [Related]
13. 3D Printing of Medicines: Engineering Novel Oral Devices with Unique Design and Drug Release Characteristics. Goyanes A; Wang J; Buanz A; Martínez-Pacheco R; Telford R; Gaisford S; Basit AW Mol Pharm; 2015 Nov; 12(11):4077-84. PubMed ID: 26473653 [TBL] [Abstract][Full Text] [Related]
14. 3D Printing of Metformin HCl PVA Tablets by Fused Deposition Modeling: Drug Loading, Tablet Design, and Dissolution Studies. Ibrahim M; Barnes M; McMillin R; Cook DW; Smith S; Halquist M; Wijesinghe D; Roper TD AAPS PharmSciTech; 2019 May; 20(5):195. PubMed ID: 31119403 [TBL] [Abstract][Full Text] [Related]
15. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets. Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424 [TBL] [Abstract][Full Text] [Related]
16. Drug Incorporation into Polymer Filament Using Simple Soaking Method for Tablet Preparation Using Fused Deposition Modeling. Tagami T; Kuwata E; Sakai N; Ozeki T Biol Pharm Bull; 2019; 42(10):1753-1760. PubMed ID: 31582663 [TBL] [Abstract][Full Text] [Related]
17. Fused-filament 3D printing of drug products: Microstructure analysis and drug release characteristics of PVA-based caplets. Goyanes A; Kobayashi M; Martínez-Pacheco R; Gaisford S; Basit AW Int J Pharm; 2016 Nov; 514(1):290-295. PubMed ID: 27863674 [TBL] [Abstract][Full Text] [Related]
18. Defined drug release from 3D-printed composite tablets consisting of drug-loaded polyvinylalcohol and a water-soluble or water-insoluble polymer filler. Tagami T; Nagata N; Hayashi N; Ogawa E; Fukushige K; Sakai N; Ozeki T Int J Pharm; 2018 May; 543(1-2):361-367. PubMed ID: 29605693 [TBL] [Abstract][Full Text] [Related]
19. How to Obtain the Maximum Properties Flexibility of 3D Printed Ketoprofen Tablets Using Only One Drug-Loaded Filament? Pyteraf J; Jamróz W; Kurek M; Szafraniec-Szczęsny J; Kramarczyk D; Jurkiewicz K; Knapik-Kowalczuk J; Tarasiuk J; Wroński S; Paluch M; Jachowicz R Molecules; 2021 May; 26(11):. PubMed ID: 34067434 [TBL] [Abstract][Full Text] [Related]
20. Channelled tablets: An innovative approach to accelerating drug release from 3D printed tablets. Sadia M; Arafat B; Ahmed W; Forbes RT; Alhnan MA J Control Release; 2018 Jan; 269():355-363. PubMed ID: 29146240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]